The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients

被引：0

作者：

Ueda, M ^{[1
]}

Hirokane, G ^{[1
]}

Morita, S ^{[1
]}

Yokono, A ^{[1
]}

Okawa, M ^{[1
]}

Shimoda, K ^{[1
]}

机构：

[1] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S223 / S223

页数：1

共 50 条

[41] Dynamics and persistence of CYP2D6 inhibition by paroxetine [J].

Jurica, J. ;

Zourkova, A. .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (04) :294-300

[42] The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients [J].

Yokono, A ;

Morita, S ;

Someya, T ;

Hirokane, G ;

Okawa, M ;

Shimoda, K .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (06) :549-555

[43] Impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients [J].

Shimoda, K ;

Someya, T ;

Yokono, A ;

Morita, S ;

Hirokane, G ;

Takahashi, S ;

Okawa, M .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (04) :371-378

[44] The effect of CYP2D6 and CYP2C19 genotypes on the metabolism of amitriptyline in Japanese psychiatric patients [J].

Hirokane, G ;

Morita, S ;

Yokono, A ;

Someya, T ;

Takahashi, S ;

Okawa, M ;

Shimoda, K .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 :S7-S8

[45] CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics [J].

Suzuki, Yutaro ;

Sugai, Takuro ;

Fukui, Naoki ;

Watanabe, Junzo ;

Ono, Shin ;

Inoue, Yoshimasa ;

Ozdemir, Vural ;

Someya, Toshiyuki .

JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (07) :908-914

[46] CYP2D6 GENOTYPE-DEPENDENT INTERACTION OF PAROXETINE AND CLARITHROMYCIN WITH THE INFERTILITY DRUG CLOMIPHENE [J].

Kerb, R. ;

Ganchev, B. ;

Boehmer, G. M. ;

Igel, S. ;

Sonnenberg, M. ;

Schaeffeler, E. ;

Schroth, W. ;

Zanger, U. ;

Brauch, H. ;

Schwab, M. ;

Muerdter, T. E. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 :S59-S59

[47] RELATIONSHIP BETWEEN CYP2D6 GENOTYPE AND HALOPERIDOL PHARMACOKINETICS AND EXTRAPYRAMIDAL SYMPTOMS IN HEALTHY VOLUNTEERS [J].

Lafuente, A. ;

Gasso, P. ;

Papagianni, K. ;

Mas, S. ;

Fernandez de Bobadilla, R. ;

Arnaiz, J. A. ;

Bernardo, M. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 :52-52

[48] Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers [J].

Gasso, Patricia ;

Papagianni, Katerina ;

Mas, Sergi ;

Fernandez de Bobadilla, Ramon ;

Albert Arnaiz, Joan ;

Bernardo, Miquel ;

Lafuente, Amalia .

PHARMACOGENOMICS, 2013, 14 (13) :1551-1563

[49] CYP2D6 genotype and tamoxifen response [J].

James M Rae ;

Matthew P Goetz ;

Daniel F Hayes ;

James N Ingle ;

Lang Li ;

Anna Maria Storniolo ;

Vered Stearns ;

David A Flockhart .

Breast Cancer Research, 7

[50] CYP2D6 phenotyping of psychiatric patients and healthy subjects [J].

Lohmann, P ;

Bagli, M ;

Mörlke, K ;

Laux, G ;

Kolbinger, M ;

Rao, ML .

PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02) :64-66

← 1 2 3 4 5 →